Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.03 USD
Change Today +0.0401 / 4.05%
Volume 2.4M
LXRX On Other Exchanges
Symbol
Exchange
LXRX is not on other exchanges.
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - lexicon pharmaceuticals inc (LXRX)

Name (Connections)Board RelationshipsTitleKey Developments
Samuel Barker Ph.D. 53 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee 
Frank Palantoni B.Sc., M.B.A. 8 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee 
Judith Swain Ph.D., M.D. 49 RelationshipsIndependent Director, Member of Audit Committee and Member of Corporate Governance Committee 

Compensation Committee* - lexicon pharmaceuticals inc (LXRX)

Name (Connections)Board RelationshipsTitle
Samuel Barker Ph.D. 53 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee
Frank Palantoni B.Sc., M.B.A. 8 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
LXRX Compensation vs. Industry
266.9K
364.1K
Chief Executive Officer
393.0K
261.5K
Chief Financial Officer
Share price activity for LEXICON PHARMACEUTICALS INC (LXRX)
52 Week Price Performance
LXRX
Industry Average

Corporate Governance Committee* - lexicon pharmaceuticals inc (LXRX)

Name (Connections)Board RelationshipsTitle
Robert Lefkowitz M.D. 48 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Compensation Committee
Judith Swain Ph.D., M.D. 49 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
LXRX and Competitor
Insiders vs. External
Board
22%
78%
Lexicon Pharmaceuticals, Inc.
8%
92%
Medtronic plc
8%
92%
Johnson & Johnson
9%
91%
Abbott Laboratories
18%
82%
CR Bard Inc.
14%
86%
Boston Scientific Corporation
Insiders
External Board Members

Advisory Committee* - lexicon pharmaceuticals inc (LXRX)

Name (Board Relationships)/Title Board Affiliations
Alan Nies 8 Relationships
Independent Director and Chairman of Medical Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LXRX:US $1.03 USD +0.0401

LXRX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $46.25 USD -0.27
Boston Scientific Corp $18.40 USD +0.24
CR Bard Inc $171.06 USD +0.19
Johnson & Johnson $99.58 USD -0.21
Medtronic PLC $76.49 USD -0.53
View Industry Companies
 

Industry Analysis

LXRX

Industry Average

Valuation LXRX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 25.7x
Price/Book 2.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEXICON PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.